Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1335-1345

  Paradowska, E ^a   Studzinska M ^a   Nowakowska, D ^b,c   Wilczynski J ^b,c   Rycel, M ^c   Suski, P ^a   Gaj, Z ^c   Kaczmarek, B ^d   Zbrog Z ^d   Lesnikowski Z J ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^d N Copernicus Provincial Specialist Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR; GLYCOPROTEIN B; TUMOR NECROSIS FACTOR ALPHA LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS DNA; MEMBRANE PROTEIN; UL144 ORF PROTEIN, HUMAN HERPESVIRUS 5; UL55 PROTEIN, HUMAN CYTOMEGALOVIRUS; US28 RECEPTOR, CYTOMEGALOVIRUS; VIRUS PROTEIN;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ETHNIC GROUP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLISH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; UL144 GENE; UL55 GENE; US28 GENE; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; AMINO ACID SEQUENCE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; POLAND; PREGNANCY; VIROLOGY;

AMINO ACID SEQUENCE; CLUSTER ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLAND; POLYMERASE CHAIN REACTION; PREGNANCY; RECEPTORS, CHEMOKINE; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIRAL PROTEINS;

EID: 84865610075     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1447-z     Document Type: Article

References (55)

1. Griffiths PD (2002) Strategies to prevent CMV infection in the neonate. Semin Neonatol 7(4):293-299. doi:10.1053/siny.2002.0123
2. Britt W (2007) HCMV: Pathogenesis and disease consequences. In: Arvin A, Campadelli-Fiume G, Mocarski E, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: Biology, therapy, and immunoprophylaxis, vol 1. Cambridge University Press, Cambridge
3. Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD et al (1982) Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Eng J Med 306(16):945-949
4. Adler SP, Nigro G, Pereira L (2007) Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Sem Perinat 31(1):10-18. doi:10.1053/j.semperi.2007.01.002
5. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome. J Clin Virol 35(2):216-220. doi:10.1016/j.jcv.2055.09.015
6. Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L et al (2002) Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 40(5):1767-1772. doi:10.1128/JCM.40.5.1767-1772.2002
7. Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS et al (2006) Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 194(4):464-473. doi:10.1086/505427
8. LanariM, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B et al (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117(1):e76-e83. doi:10.1542/peds.2005-0629
9. Paradowska E, Przepiórkiewicz M, Nowakowska D, Studzinska M, Wilczynski J, Emery VC et al (2006) Detection of cytomegalovirus infection in human placental cells by polymerase chain reaction. APMIS 114(11):764-771. doi:10.1111/j.1600-0463.2006.apm-31.x
10. Chou S, Dennison KM (1991) Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralizationrelated epitopes. J Infect Dis 163(6):1229-1234. doi:10.1093/infdis/ 163.6.1229
11. Meyer-König U, Vogelberg C, Bongarts A, Kampa D, Delbrück R, Wolff-Vorbeck G et al (1998) Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55(1):75-81. doi:10.1002/(SICI)1096-9071 (199805
12. Meyer-König U, Haberland M, von Laer D, Haller O, Hufert FT (1998) Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 177(5):1162-1169. doi:10.1086/515262
13. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF (2011) Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 7(5): E1001344. doi:10.1371/journal.ppat.1001344
14. Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D et al (2002) Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor alpha and beta chemokine receptors in congenital CMV disease. J Infect Dis 186(8):1057-1064. doi:10.1086/344238
15. Bale JF, Petheram SJ, Robertson M, Murph JR, Demmler G (2001) Human cytomegalovirus A sequence and UL144 variability in strains from infected children. J Med Virol 65(1):90-96. doi:10.1002/jmv.2006
16. Mao ZQ, He R, Sun M, Qi Y, Huang YJ, Ruan Q (2007) The relationship between polymorphisms of HCMV UL144 ORF and clinical manifestations in 73 strains with congenital and/or perinatal HCMV infection. Arch Virol 152(1):115-124. doi:10.1007/s00705-006-0826-8
17. Picone O, Costa J-M, Chaix M-L, Ville Y, Rouzioux C, Leruez-Ville M (2005) Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 43(1):25-29. doi:10.1128/JCM.43.1.25-29.2005
18. Stranska R, Schuurman R, Toet M, Verboon-Maciolek M, de Vries LS, van Loon AM (2006) Application of UL144 molecular typing to determine epidemiology of cytomegalovirus infections in preterm infants. J Clin Microbiol 44(3):1108-1110. doi:10.1128/JCM.44.3.1108-1110.2006
19. Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E et al (1999) Human cytomegalovirus UL144 open reading frame: Sequence hypervariability in low-passage clinical isolates. J Virol 73(12):10040-10050
20. Arav-Boger R, Foster CB, Zong JC, Pass RF (2006) Human cytomegalovirus-encoded alpha chemokines exhibit high sequence variability in congenitally infected newborns. J Infect Dis 193(6):788-791. doi:10.1086/500508
21. Arista S, De Garcia S, Giammanco GM, Di Carlo P, Iannitto E (2003) Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations. Arch Virol 148(3):547-554. doi:10.1007/s00705-002-0941-0
22. Bale JF, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ (2000) Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 182(3):933-936. doi:10.1086/315770
23. Barbi M, Binda S, Caroppo S, Primache V, Didò P, Guidotti P et al (2001) CMV gB genotypes and outcome of vertical transmission study on dried blood spots of congenitally infected babies. J Clin Virol 21(1):75-79. doi:10.1016/S1386-6532(00) 00188-8
24. Jin H, Wang X, Li S (2007) Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants. Intervirology 50(3):219-223. doi:10.1159/000100564
25. Lukácsi A, Taródi B, Endreffy E, Bábinszki A, Pál A, Pusztai R (2001) Human cytomegalovirus gB genotype 1 is dominant in congenital infections in south Hungary. J Med Virol 65(3):537-542. doi:10.1002/jmv.2070
26. Trincado DE, Scott G, White A, Hunt C, Rasmussen L, Rawlinson WD (2000) Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 61(4):481-487. doi:10.1002/1096-9071(200008)61:4
27. Yamamoto AY, Mussi-Pinhata MM, de Deus Wagatsuma VM, Marin LJ, Duarte G, Figueiredo LT (2007) Human cytomegalovirus glycoprotein B genotypes in Brazilian mothers and their congenitally infected infants. J Med Virol 79(8):1164-1168. doi:10.1002/jmv.20903
28. Pignatelli S, Dal Monte P, Rossini G, Lazzarotto T, Gatto MR, Landini MP (2003) Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol 28(1):38-43. doi:10.1016/S1386-6532(02)00236-6
29. Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P et al (1999) Cutting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162(12):6967-6970
30. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW et al (1999) Cytomegalovirus encodes a potent chemokine. Proc Natl Acad Sci USA 96(17):9839-9845
31. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L et al (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus- infected cells. J Exp Med 188 (5):855-866
32. Casarosa P, Waldhoer M, LiWang PJ, Vischer HF, Kledal T, Timmerman H et al (2005) CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirusencoded US28 receptor. J Biol Chem 280(5):3275-3285. doi:10.1074/jbc.M407536200
33. Gao J-L, Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional ß chemokine receptor. J Biol Chem 269(46):28539-28542
34. Kuhn DE, Beall CJ, Kolattukudy PE (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211(1):325-330. doi:10.1006/ bbrc.1995.1814
35. Boomker JM, The TH, de Leij LF, Harmsen MC (2006) The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer. Virus Res 118(1):196-200. doi:10.1016/j.virusres.2005.12.011
36. Pleskoff O, Tréboute C, Alizon M (1998) The cytomegalovirusencoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol 72(8):6389-6397
37. Pleskoff O, Casarosa P, Verneuil L, Ainoun F, Beisser P, Smit M et al (2005) The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS J 272 ):4163-4177. doi:10.1111/j.1742-4658. 2005.04829.x
38. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not fund in laboratory strains. J Virol 70(1):78-83
39. Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC et al (1998) Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retrovir 14 (6):533-536
40. Hassan-Walker A, Mattes FM, Griffiths PD, Emery VC (2001) Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts. J Med Virol 64:283-289. doi:10.1002/jmv.1048
41. Temperton NJ, Quenelle DC, Lawson KM, Zuckerman JN, Kern ER, Griffiths PD et al (2003) Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: Adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. J Med Virol 70:86-90. doi:10.1002/jmv.10357
42. Halwachs-Baumann G, Genser B, Pailer S, Engele H, Rosegger H, Schalk A et al (2002) Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol 25 [Suppl 3]:S81-S87. doi:10.1016/S1386-6532(02) 00188-9
43. Rybka K, Orzechowska B, Siemieniec I, Leszek J, Zaczynska E, Pajak J, Blach-Olszewska Z (2003) Age related natural antiviral non-specific immunity of human leukocytes. Med Sci Monit 9 (12):BR413-BR417
44. Paradowska E, Blach-Olszewska Z, Gejdel E (1997) Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta 18:441-446
45. Paradowska E, Blach-Olszewska Z, Sender J, Jarosz W (1996) Antiviral nonspecific immunity of human placenta at term: Possible role of endogenous tumor necrosis factors and interferons. J Interferon Cytokine Res 16:941-948
46. Waters A, Hassan J, deGascun C, Kissoon G, Knowles S, Molloy E et al (2010) Human cytomegalovirus UL144 is associated with viremia and infant development sequel in congenital infection. J Clin Microbiol 48(11):3956-3962. doi:10.1128/JCM.01133-10
47. Heo J, Petheram S, Demmler G, Murph JR, Adler SP, Bale J et al (2008) Polymorphisms within human cytomegalovirus chemokine (UL146/147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 378(1):86-96. doi:10.1016/j.virol.2008.05.002
48. Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ et al (2003) The human cytomegalovirus genome revisited: Comparison with chimpanzee cytomegalovirus genome. J Gen Virol 84(4):17-28. doi:10.1099/vir.0.18606-0
49. Arav-Boger R, Boger YS, Foster CB, Boger Z (2008) The use of artificial neural networks in prediction of congenital CMV outcome from sequence data. Bioinform Biol Insights 2:281-289
50. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O et al (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 103(35):13068-13073. doi:10.1073/pnas. 0604433103
51. Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK et al (2009) The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 69(7):2861-2869. doi:10.1158/0008-5472.CAN-08-2487
52. Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y (2004) Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected foetuses. Prenat Diagn 24(12):1001-1006. doi:10.1002/pd.942
53. Yan H, Koyano S, Inami Y, Yamamoto Y, Suzutani T, Mizuguchi M et al (2008) Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 153 (4):667-674. doi:10.1007/s00705-008-0044-7
54. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G (2004) Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39(2):155-161. doi:10.1086/421496
55. Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, de Frizzo Oliveira P et al (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202(3):297.e1-297.e8. doi:10.1016/j. ajog.2009.11.018